Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study

Table 3 Clinical characteristics of individuals in the VITD group

									25(OH)D levels
	Gender	Age	BMI	Diagnosis	Gastrointestinal function	Application	VP	MV	Day 0	Day 3	Day 7
02	female	83	33.2	Pneumonia	normal	FT	yes	yes	13.7	64.2	59.4
05	male	72	30.1	Heart failure, renal transplant	normal	FT	yes	yes	12.2	33.1	34.8
06	male	77	21.1	Myelodysplastic syndrome, sepsis	normal	O	no	no	10.1	36.5	-
08	male	84	23.1	Pneumonia	normal	FT	yes	yes	16.0	50.6	63.4
11	male	55	36.6	Wegener's granulomatosis, renal failure	normal	FT	no	yes	10.8	26.9	29.8
14	female	45	21.7	CPR (near-drowning)	hypoxic gastrointestinal dysfunction	FT	yes	yes	9.7	8.3	10.3
15	male	78	27.0	Seizures	normal	FT	no	yes	10.1	63.5	-
16	male	58	27.4	H1N1 influenza, renal transplant	normal	O	no	no	13.7	30.5	50.3
18	male	47	27.5	H1N1 influenza, renal transplant	normal	FT	yes	yes	15.1	42.9	29.3
22	female	51	24.8	CPR (ventricular fibrillation)	normal	FT	yes	yes	12.8	36.6	43.6
25	male	46	17.3	Allogeneic stem cell transplantation for chronic myeloid leukemia	sclerodermiform gastrointestinal graft-versus-host disease	FT	yes	yes	15.4	24.5	22.1
26	male	37	54.6	Pneumonia	normal	FT	yes	yes	12.0	33.0	38.8

25(OH)D, 25-hydroxyvitamin D, BMI, body mass index; CPR, cardiopulmonary resuscitation; FT, feeding tube; MV, mechanical ventilation; O, oral; VITD, vitamin D; VP, vasopressor.

ISSN: 1364-8535